
Mark Andrew Zenker MD FACC, FASE
Echocardiography, Cardiothoracic Imaging, Cardiovascular Disease Genetics
Director of the St. THOMAS Heart HCM, Amyloid, and Aortic Clinics
Join to view full profile
4230 Harding RdSuite 330Nashville, TN 37205
Phone+1 615-269-4545
Dr. Zenker is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Vanderbilt University Medical CenterFellowship, Cardiovascular Disease, 1992 - 1995
Vanderbilt University Medical CenterResidency, Internal Medicine, 1989 - 1992
Southern Illinois University School of MedicineClass of 1989
Certifications & Licensure
KY State Medical License 2001 - 2027
TN State Medical License 1990 - 2026
American Board of Internal Medicine Cardiovascular Disease
American Board of Nuclear Medicine Nuclear Medicine- American Society of EchoFellow
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification athenaClinicals, athenahealth, Inc., 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification athenaClinicals, athenahealth, Inc., 2014, 2016-2017
- FASE American Society of Echo, 2010
Publications & Presentations
PubMed
- 2 citationsIncidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study.Olives Nguyen, Jack Wiedrick, Daniele Massera, Elizabeth Adlestein, Sumar Frejat
Journal of Cardiac Failure. 2026-03-01 - 1 citationsLong-Term Favorable Cardiac Remodeling in Obstructive Hypertrophic Cardiomyopathy Patients Treated With Mavacamten for Up to 128 Weeks: Insights From the VALOR-HCM Trial.Milind Y Desai, Yuichiro Okushi, Kathy Wolski, Jeffrey B Geske, Anjali Tiku Owens
JACC. Cardiovascular Imaging. 2025-12-01 - 2 citationsIncidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study.Olives Nguyen, Jack Wiedrick, Daniele Massera, Elizabeth Adlestein, Sumar Frejat
Medrxiv. 2025-09-19
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









